A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors. Lifileucel led to ...
A father-of-two with a rare form of cancer hopes his family's experience will help people start conversations with their ...
Efficacy and safety of first-line (1L) nivolumab plus relatlimab (NIVO + RELA) versus NIVO plus ipilimumab (NIVO + IPI) in advanced melanoma: An updated indirect treatment comparison (ITC) with 4-year ...
Treatment-free survival after immunotherapy discontinuation in advanced melanoma: A systematic review and meta-analysis of real-world studies. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Researchers review melanoma subtypes, focusing on therapeutic advances in metastatic ocular melanoma, including TILs, ImmTACs, and targeted therapies.
While Jodie and Joe had organised their wedding for the end of September 2024, a week before the big day they got a call ...
The kids are almost out of school, your shorts have mysteriously shrunk in the dryer and you can’t find your favorite pair of sunglasses. Yes, summer is nigh and that goose-pimpled winter flesh you’ve ...
While no one can control their health completely, at this point it would be naive to think that the odds of getting cancer are completely left up to chance. The World Health Organization estimates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback